A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry

Sheng Pan, David Zhu, Joseph Quinn, Elaine R. Peskind, Thomas J. Montjne, Biaoyang Lin, David R. Goodlett, Greg Taylor, Jimmy Eng, Jing Zhang

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

Human cerebrospinal fluid (CSF) is an important source for studying protein biomarkers of age-related neurodegenerative diseases. Before characterizing biomarkers unique to each disease, it is necessary to categorize CSF proteins systematically and extensively. However, the enormous complexity, great dynamic range of protein concentrations, and tremendous protein heterogeneity due to post-translational modification of CSF create significant challenges to the existing proteomics technologies for an in-depth, nonbiased profiling of the human CSF proteome. To circumvent these difficulties, in the last few years, we have utilized several different separation methodologies and mass spectrometric platforms that greatly enhanced the identification coverage and the depth of protein profiling of CSF to characterize CSF proteome. In total, 2594 proteins were identified in well-characterized pooled human CSF samples using stringent proteomics criteria. This report summarizes our efforts to comprehensively characterize the human CSF proteome to date.

Original languageEnglish (US)
Pages (from-to)469-473
Number of pages5
JournalProteomics
Volume7
Issue number3
DOIs
StatePublished - Feb 2007

Fingerprint

Cerebrospinal fluid
Cerebrospinal Fluid Proteins
Tandem Mass Spectrometry
Chromatography
Mass spectrometry
Cerebrospinal Fluid
Proteome
Biomarkers
Proteomics
Proteins
Neurodegenerative diseases
Depth profiling
Post Translational Protein Processing
Neurodegenerative Diseases
Datasets
Technology

Keywords

  • Alzheimer's disease
  • Human cerebrospinal fluid
  • Mass spectrometry
  • Parkinson's disease

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry. / Pan, Sheng; Zhu, David; Quinn, Joseph; Peskind, Elaine R.; Montjne, Thomas J.; Lin, Biaoyang; Goodlett, David R.; Taylor, Greg; Eng, Jimmy; Zhang, Jing.

In: Proteomics, Vol. 7, No. 3, 02.2007, p. 469-473.

Research output: Contribution to journalArticle

Pan, S, Zhu, D, Quinn, J, Peskind, ER, Montjne, TJ, Lin, B, Goodlett, DR, Taylor, G, Eng, J & Zhang, J 2007, 'A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry', Proteomics, vol. 7, no. 3, pp. 469-473. https://doi.org/10.1002/pmic.200600756
Pan, Sheng ; Zhu, David ; Quinn, Joseph ; Peskind, Elaine R. ; Montjne, Thomas J. ; Lin, Biaoyang ; Goodlett, David R. ; Taylor, Greg ; Eng, Jimmy ; Zhang, Jing. / A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry. In: Proteomics. 2007 ; Vol. 7, No. 3. pp. 469-473.
@article{6d9febad56dc4d93b9331f70a5dded7f,
title = "A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry",
abstract = "Human cerebrospinal fluid (CSF) is an important source for studying protein biomarkers of age-related neurodegenerative diseases. Before characterizing biomarkers unique to each disease, it is necessary to categorize CSF proteins systematically and extensively. However, the enormous complexity, great dynamic range of protein concentrations, and tremendous protein heterogeneity due to post-translational modification of CSF create significant challenges to the existing proteomics technologies for an in-depth, nonbiased profiling of the human CSF proteome. To circumvent these difficulties, in the last few years, we have utilized several different separation methodologies and mass spectrometric platforms that greatly enhanced the identification coverage and the depth of protein profiling of CSF to characterize CSF proteome. In total, 2594 proteins were identified in well-characterized pooled human CSF samples using stringent proteomics criteria. This report summarizes our efforts to comprehensively characterize the human CSF proteome to date.",
keywords = "Alzheimer's disease, Human cerebrospinal fluid, Mass spectrometry, Parkinson's disease",
author = "Sheng Pan and David Zhu and Joseph Quinn and Peskind, {Elaine R.} and Montjne, {Thomas J.} and Biaoyang Lin and Goodlett, {David R.} and Greg Taylor and Jimmy Eng and Jing Zhang",
year = "2007",
month = "2",
doi = "10.1002/pmic.200600756",
language = "English (US)",
volume = "7",
pages = "469--473",
journal = "Proteomics",
issn = "1615-9853",
publisher = "Wiley-VCH Verlag",
number = "3",

}

TY - JOUR

T1 - A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry

AU - Pan, Sheng

AU - Zhu, David

AU - Quinn, Joseph

AU - Peskind, Elaine R.

AU - Montjne, Thomas J.

AU - Lin, Biaoyang

AU - Goodlett, David R.

AU - Taylor, Greg

AU - Eng, Jimmy

AU - Zhang, Jing

PY - 2007/2

Y1 - 2007/2

N2 - Human cerebrospinal fluid (CSF) is an important source for studying protein biomarkers of age-related neurodegenerative diseases. Before characterizing biomarkers unique to each disease, it is necessary to categorize CSF proteins systematically and extensively. However, the enormous complexity, great dynamic range of protein concentrations, and tremendous protein heterogeneity due to post-translational modification of CSF create significant challenges to the existing proteomics technologies for an in-depth, nonbiased profiling of the human CSF proteome. To circumvent these difficulties, in the last few years, we have utilized several different separation methodologies and mass spectrometric platforms that greatly enhanced the identification coverage and the depth of protein profiling of CSF to characterize CSF proteome. In total, 2594 proteins were identified in well-characterized pooled human CSF samples using stringent proteomics criteria. This report summarizes our efforts to comprehensively characterize the human CSF proteome to date.

AB - Human cerebrospinal fluid (CSF) is an important source for studying protein biomarkers of age-related neurodegenerative diseases. Before characterizing biomarkers unique to each disease, it is necessary to categorize CSF proteins systematically and extensively. However, the enormous complexity, great dynamic range of protein concentrations, and tremendous protein heterogeneity due to post-translational modification of CSF create significant challenges to the existing proteomics technologies for an in-depth, nonbiased profiling of the human CSF proteome. To circumvent these difficulties, in the last few years, we have utilized several different separation methodologies and mass spectrometric platforms that greatly enhanced the identification coverage and the depth of protein profiling of CSF to characterize CSF proteome. In total, 2594 proteins were identified in well-characterized pooled human CSF samples using stringent proteomics criteria. This report summarizes our efforts to comprehensively characterize the human CSF proteome to date.

KW - Alzheimer's disease

KW - Human cerebrospinal fluid

KW - Mass spectrometry

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=33847151166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847151166&partnerID=8YFLogxK

U2 - 10.1002/pmic.200600756

DO - 10.1002/pmic.200600756

M3 - Article

C2 - 17211832

AN - SCOPUS:33847151166

VL - 7

SP - 469

EP - 473

JO - Proteomics

JF - Proteomics

SN - 1615-9853

IS - 3

ER -